Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib

Clinical trial NCT01933945 · COMPLETED

Trial details

NCT number: NCT01933945
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Hepatocellular

Start date: 2013-10-28
Primary completion: 2017-07-22
Enrollment: 1676

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.